11 months ago

2019 Spring/Summer Highlights of Hope


RESEARCH STAND UP TO CANCER 2018 GLOBAL TELECAST HONORS VAN ANDEL INSTITUTE’S ANN SCHOEN AS AN “EVERYDAY HERO” On Sept. 7, Van Andel Institute (VAI) participated in Stand Up To Cancer’s (SU2C) 2018 telecast, helping to raise a record-breaking 3 million for cancer research programs. During the live event, VAI employee and 16-year breast cancer surivivor Ann Schoen shared her story in a video segment called Everyday Heroes. The telecast aired on more than 70 network and broadcast platforms around the world and brought together some of the entertainment industry’s biggest stars. Millions of people tuned into the broadcast, which was executive produced by award-winning actor and director Bradley Cooper and included appearences by celebrities including Jason Bateman, Kathy Bates, James Corden, Katie Couric, Matt Damon, Julia Louis-Dreyfus, Jennifer Garner, Matthew McConaughey and Sofia Vergara. Schoen appeared in a video featuring cancer survivors and was recognized with them onstage during the event. “Stand Up To Cancer has established a wonderful community of support, bringing researchers and advocates together to fight cancer,” Schoen said. “I was thrilled to represent the Institute and be a part of this inspiring event.” Stand Up To Cancer encourages scientists to collaborate with each other rather than compete to accelerate the pace of research and deliver promising new treatments to patients. The Institute began working closely with SU2C in 2014 when it became home to the Van Andel Research Institute–Stand Up To Cancer (VARI–SU2C) Epigenetics Dream Team, which is led by Dr. Peter A. Jones, VARI’s Chief Scientific Officer, and Dr. Stephen Baylin, a VARI Director’s Scholar and Virginia and D.K. Ludwig Professor for Cancer Research at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Jones and Baylin are the leaders of the original SU2C Epigenetics Dream Team, which was founded in 2009. Today, more than 500 people in the U.S. and abroad are enrolled in clinical trials run through this powerful collaborative partnership between VARI and SU2C. Schoen had worked at the Institute for six years when she was diagnosed with breast cancer in 2002. In an instant, she became one of thousands of Americans who are diagnosed with cancer every day. Schoen said it was one of the most difficult chapters of her life, but she found solace in the sense of hope she received from her coworkers at VAI. DR. STEPHEN BAYLIN, ANN SCHOEN & DR. PETER A. JONES. “I was diagnosed with cancer while working at a cancer research institute,” Schoen said, “The people here understood what I was up against, and they gave me the encouragement I needed.” 6 | VAN ANDEL INSTITUTE HIGHLIGHTS OF HOPE

For many people like Schoen, the fight against cancer is long and arduous, and the love, compassion and support of family, friends and colleagues offers a much appreciated comfort. She also found strength in the fact that she was working for an organization dedicated to stopping cancer and making life better for those affected by this devastating disesase. Today, Schoen’s battle is behind her, but she is deeply grateful for the role biomedical research played in the development of the treatments that saved her life. “These scientists are such rock stars,” Schoen said. “I’m so honored to work with them and support their efforts to find new and better treatments for cancer patients. As far as we’ve come, we still have progress to make. The VARI–SU2C Epigenetics Dream Team is bringing us one step closer to ending this disease, and I know we won’t quit until we reach our goal of a world that is cancer free.” Learn more about the VARI–SU2C Epigenetics Dream Team at Today, Schoen’s battle is behind her, but she is deeply grateful for the role biomedical research played in the development of the treatments that saved her life. CANCER SURVIVORS BEING HONORED DURING THE 2018 STAND UP TO CANCER GLOBAL TELECAST (ANN SCHOEN PICTURED ON THE FAR RIGHT). VAN ANDEL INSTITUTE HIGHLIGHTS OF HOPE | 7

Publications by Year